Stephanie Graff, MD, FACP, FASCO (@drsgraff) 's Twitter Profile
Stephanie Graff, MD, FACP, FASCO

@drsgraff

Director Breast Oncology, Lifespan Cancer Institute | Assoc Prof Legorreta Cancer Center Brown Univ | Views Mine | vivo.brown.edu/display/sgraff | COI ⬇

ID: 838389180484898816

linkhttps://coi.asco.org/share/NPU-PUCW/Stephanie%20Graff calendar_today05-03-2017 14:02:11

14,14K Tweet

19,19K Followers

3,3K Following

Brown University (@brownuniversity) 's Twitter Profile Photo

Brown University students and swimmers Amie Barrow and Zehra Bilgin are headed to #Paris2024 to compete in the 2024 Olympic Games, joining a trio of Brown alumni competing in rowing and coaching rugby. Brown Alumni & Friends brown.edu/news/2024-07-2…

Adam Grant (@adammgrant) 's Twitter Profile Photo

The most important reason to treat people well is not what you'll get in return. It's who you hope to become. Kindness is not about reciprocity or karma. It's about character. Civility doesn't need to be justified with consequences. Respecting others is the right thing to do.

The most important reason to treat people well is not what you'll get in return. It's who you hope to become.

Kindness is not about reciprocity or karma. It's about character.

Civility doesn't need to be justified with consequences. Respecting others is the right thing to do.
Dr. Emily K. Drake (@ek_drake) 's Twitter Profile Photo

📢 I am thrilled to share that I will be part of this Brown University CME course faculty! 👇 Check out the agenda and registration info below! #AYACSM #BCSM #BTSM #LCSM #ChildhoodCancer #OncTwitter #MedTwitter Dal Health

OncoAlert (@oncoalert) 's Twitter Profile Photo

Just out🚨 at Journal of Clinical Oncology Prospective Study of Supplemental Screening With Contrast-Enhanced Mammography in Women With Elevated Risk of Breast Cancer Evaluated the efficacy of contrast-enhanced mammography (CEM) as a supplemental screening tool in women aged 3⃣5⃣ and older at

Just out🚨 at <a href="/JCO_ASCO/">Journal of Clinical Oncology</a> 
Prospective Study of Supplemental Screening With Contrast-Enhanced Mammography in Women With Elevated Risk of Breast Cancer

Evaluated the efficacy of contrast-enhanced mammography (CEM) as a supplemental screening tool in women aged 3⃣5⃣ and older at
COSMO (@cosmocollab) 's Twitter Profile Photo

Roberta Lombardi will be moderating a breakout session on community building and stakeholder engagement at #COSMO24! Will be a great opportunity for networking & brainstorming ways on growing the oncology community on social media to improve outcomes! 🔗 in profile to sign up!

<a href="/Robertalom3/">Roberta Lombardi</a> will be moderating a breakout session on community building and stakeholder engagement at #COSMO24! 

Will be a great opportunity for networking &amp; brainstorming ways on growing the oncology community on social media to improve outcomes!  

🔗 in profile to sign up!
Oncology Times (@oncologytimes) 's Twitter Profile Photo

A new study has found significant #racialdisparities in the presentation and survival outcomes of women diagnosed with invasive lobular carcinoma. Read more: ow.ly/E6zG50SPyTK #BreastCancer #CancerResearch

A new study has found significant #racialdisparities in the presentation and survival outcomes of women diagnosed with invasive lobular carcinoma. Read more: ow.ly/E6zG50SPyTK #BreastCancer #CancerResearch
ABC Global Alliance (@abcglobalall) 's Twitter Profile Photo

Su experiencia con el cancer de mama metastásico/avanzado importa! 📢​ Si es usted paciente con cancer de mama metastásico o Avanzado o un professional de la salud, le rogamos que dedique 15 minutos a responder nuestra encuesta.​ 🌐 shorturl.at/xq0dC ​ OncoAlert

Janice Cowden (@janicetnbcmets) 's Twitter Profile Photo

And, please, PLEASE do not refer to #metastaticbreastcancer as a chronic disease when the median OS at 5 yrs from dx is < 90-100%! Currently at about 30% mOS at 5 yrs. We’re not even close - especially for younger women & more aggressive subtypes like #TNBC - which is <20% mOS

COSMO (@cosmocollab) 's Twitter Profile Photo

We cannot wait to hear Stephanie Graff, MD, FACP, FASCO’s insights during the roundtable discussion all about digital opinion leaders! 🔗Registration is filling up fast!! ⏭️ cme-learning.brown.edu/COSMO-24 #COSMO24 Eleonora Teplinsky, MD Martina Murphy, MD

We cannot wait to hear <a href="/DrSGraff/">Stephanie Graff, MD, FACP, FASCO</a>’s insights during the roundtable discussion all about digital opinion leaders! 
🔗Registration is filling up fast!! ⏭️ cme-learning.brown.edu/COSMO-24 
#COSMO24 <a href="/drteplinsky/">Eleonora Teplinsky, MD</a> <a href="/DrMMurphy/">Martina Murphy, MD</a>
Dr Steven Quay (@quay_dr) 's Twitter Profile Photo

An absolutely remarkable #Covid paper from UCSF. What did they find? 1. Fibrin binds spike protein 2. Forms proinflammatory blood clots 3. Clots drive systemic thromboinflammation & brain pathology, including #LongCovid 4. NK cell loss is seen & explains increase in #cancer

An absolutely remarkable #Covid paper from UCSF.

What did they find?

1. Fibrin binds spike protein
2. Forms proinflammatory blood clots
3. Clots drive systemic thromboinflammation &amp; brain pathology, including #LongCovid  
4. NK cell loss is seen &amp; explains increase in #cancer
Santiesteban (@s_santiesteban) 's Twitter Profile Photo

🗒️BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing #BCSM nature.com/articles/s4141…

🗒️BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing

#BCSM

nature.com/articles/s4141…
Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

Two weeks to #ESMO24. Multiple important breast onc trials readouts across disease subtypes, including OS from KN522, DB12, 4y of NATALEE, CAPItello290, phase 1 studies of novel ADCs, IO, targeted drugs, and so much more. The countdown is on. See you soon in Barcelona! 🇪🇸 #bcsm

Two weeks to #ESMO24. Multiple important breast onc trials readouts across disease subtypes, including OS from KN522, DB12, 4y of NATALEE, CAPItello290, phase 1 studies of novel ADCs, IO, targeted drugs, and so much more. The countdown is on. See you soon in Barcelona! 🇪🇸 #bcsm
Stephanie Graff, MD, FACP, FASCO (@drsgraff) 's Twitter Profile Photo

Going to #ESMO24 & excited for expert talks + seeing colleagues in a beautiful European city? Or ru having FOMO? Either way, the next chance is on the horizon! 👀 at the St.Gallen Breast Ca Consensus Conf panelists! Hope u join me in Vienna!#SGBCC2025 sg-bcc.org/programme/pane…

Going to #ESMO24 &amp; excited for expert talks + seeing colleagues in a beautiful European city? Or ru having FOMO?

Either way, the next chance is on the horizon! 👀 at the St.Gallen Breast Ca Consensus Conf panelists! 

Hope u join me in Vienna!#SGBCC2025 

sg-bcc.org/programme/pane…
Stephanie Graff, MD, FACP, FASCO (@drsgraff) 's Twitter Profile Photo

A beautifully crafted review “Towards targeting the breast cancer immune microenvironment” in Nature Reviews Cancer by Sherene Loi, MD et al not only closes a gap in our up to date understanding of immune microenvironment, but is graphically 🔝 Bravo. Required read. nature.com/articles/s4156…

A beautifully crafted review “Towards targeting the breast cancer immune microenvironment” in <a href="/NatureRevCancer/">Nature Reviews Cancer</a> by <a href="/LoiSher/">Sherene Loi, MD</a> et al not only closes a gap in our up to date understanding of immune microenvironment, but is graphically 🔝
Bravo. Required read. 
nature.com/articles/s4156…
Stephanie Graff, MD, FACP, FASCO (@drsgraff) 's Twitter Profile Photo

❓🩻 What is the role of #PETscan in #breastcancer? Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer ncbi.nlm.nih.gov/pmc/articles/P…